Cargando…
Reduced 5-Methylcytosine Level as a Potential Progression Predictor in Patients with T1 or Non-Invasive Urothelial Carcinoma
This study aims to elucidate the level of DNA methylation in urothelial carcinomas (UCs) using 5-methylcytosine (5-MeC) immunohistochemistry (IHC). We examined the relationship among 5-MeC levels, DNA (cytosine-5)-methyltransferase 1 (DNMT1) immunostaining levels, and clinicopathologic features. Tis...
Autores principales: | Chung, Chi-Jung, Chang, Chao-Hsiang, Chuu, Chih-Pin, Yang, Chi-Rei, Chang, Yi-Huei, Huang, Chi-Ping, Chen, Wen-Chi, Chung, Mu-Chi, Chang, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307268/ https://www.ncbi.nlm.nih.gov/pubmed/25561224 http://dx.doi.org/10.3390/ijms16010677 |
Ejemplares similares
-
Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
por: Hung, Peir-Haur, et al.
Publicado: (2016) -
Association of DNA Methyltransferases 3A and 3B Polymorphisms, and Plasma Folate Levels with the Risk of Urothelial Carcinoma
por: Chung, Chi-Jung, et al.
Publicado: (2014) -
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma
por: Lin, Shih-Yi, et al.
Publicado: (2016) -
Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan
por: Chung, Chi-Jung, et al.
Publicado: (2012) -
Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014)